PR PolyResearch

Join Free

NASDAQ

Profound Medical Corp. (PROF)

♥ 371 Thanks from members

Profound Medical Corp. (PROF) exhibits a bifurcated market profile, blending an impressive 104% first-quarter 2026 revenue growth and an EPS beat with severe structural concerns regarding cash runway depletion and persistent shareholder dilution.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)